SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-034423
Filing Date
2024-07-26
Accepted
2024-07-26 16:59:42
Documents
7
Period of Report
2024-09-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20026685x1_def14a.htm DEF 14A 844846
2 logo_roivant02.jpg GRAPHIC 34616
3 logo_roivant02x1.jpg GRAPHIC 32659
4 ny20026685x1_bargraph01.jpg GRAPHIC 99534
5 ny20026685x1_bargraph02.jpg GRAPHIC 116908
6 ny20026685x1_pc01.jpg GRAPHIC 765900
7 ny20026685x1_pc02.jpg GRAPHIC 575072
  Complete submission text file 0001140361-24-034423.txt   3082031
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-40782 | Film No.: 241147874
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)